Coinciding with the Bureau’s Consumer Financial Protection week, this event will focus on how the Bureau is protecting consumers in the financial marketplace, the issues consumers are confronting, as well as informing consumers how they can communicate to the Bureau any issues that they may have with a financial services provider. These topics are particularly compelling in the face of unprecedented challenges posed by the COVID-19 pandemic. Director Kraninger will also deliver prepared remarks during the presentation.
The Consumer Financial Protection Bureau (CFPB) is an independent Federal agency established under the Dodd-Frank Act to create a single point of accountability in the Federal government for consumer financial protection. In carrying out its mission, the Bureau conducts rule-making, supervision, and enforcement with respect to the Federal consumer financial laws; handles consumer complaints and inquiries; promotes financial education; researches consumer behavior; and monitors financial markets for risks to consumers. Director Kraninger was confirmed by the U.S. Senate in December 2018, following a career in government service including roles in the Office of Management and Budget, Department of Homeland Security, and the U.S. Senate.
How are patient organizations taking on the challenge of diversity, equity, and inclusion within biomedical research to create better health outcomes for all patient populations, especially those historically excluded from research and...
Rajiv Ahuja, associate director at the Milken Institute, focusing on the future of aging, moderates this Advances in Science webinar with featured guest Richard J. Hodes, M.D., Director of the National Institute on Aging (NIA) at the...
How are nonprofit organizations leveraging venture philanthropy to accelerate the development of treatments and cures? As part of The Research Acceleration and Innovation Network (TRAIN) webinar series, FasterCures takes a deeper dive into...
Despite significant advances in renewable energy, biotech, and life sciences jobs, the journey from generating breakthrough discoveries to creating accessible jobs across green and blue industries remains difficult to quantify. Industries...
One thing has been made abundantly clear during the COVID-19 pandemic. Californians are quitting their jobs at unprecedented rates. The recent job reports only continue to solidify this notion. Whether searching for better pay, more...
While employment in much of the United States has recovered successfully from the fallout of the COVID-19 pandemic, California remains one of the few states that has struggled to recoup jobs at a pace on par with the rest of the nation...
Data from and about patients is essential to advance biomedical research and development, but its collection and dissemination can be a significant investment of time and resources for patient organizations that choose to be the...
How can patient organizations hoping to leverage the resources of industry researchers attract their support and establish formal industry partnerships? How can partnerships with industry partners ensure intellectual property considerations...